Daewoong to launch oxybutynin gel in Korea

Published: 2012-01-20 06:56:00
Updated: 2012-01-20 06:56:00
Daewoong Pharmaceutical announced Wednesday that it signed an exclusive licensing agreement with the U.S. based Antares Pharma to distribute Antares’s topical oxybutynin gel 3% product inn Korea.

Last December, The U.S. Food and Drug Administration (FDA) approved the oxybutynin product for the...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.